PC3I News
PC3I Fellow Debanjan Pain, MD has been selected as a recipient of the 2024 ASCO Conquer Cancer Young Investigator Award for a project supporting patients with prostate cancer in Sub-Saharan Africa. The Young Investigator Award provides research funding to promising young physicians to encourage quality research in clinical oncology as they transition to a faculty appointment.
The burden of prostate cancer throughout Sub-Saharan Africa is increasing, with a significant proportion of patients presenting with metastatic disease. Dr. Pain’s Young Investigator Award proposal outlines the necessary steps to mitigate barriers to efficient and optimal care delivery for patients with prostate cancer and other genitourinary malignancies in low- and middle-income countries. Leveraging the decades-long Botswana-UPenn partnership, his research strives to understand where delays arise in prostate cancer treatment and to learn directly from patients and providers, through qualitative interviews, about the care delivery cascade. Results from this study will inform future research efforts to develop interventions to provide access to timely treatment.
Dr. Pain’s mentors on this project included Penn faculty and local oncologists in Gaborone, Botswana, including PC3I faculty Katharine Rendle, Surbhi Grover, and Lawrence Shulman. He also worked with Yehoda Martei, Robert Gross, and Naomi Haas. Now finishing his hematology-oncology fellowship, Dr. Pain plans to continue his work in health services research in Botswana in his next role as Assistant Professor at MD Anderson Cancer Center.
Related News
PC3I News
Patient- and Clinician-directed Nudges Help Promote Serious Illness Conversations
07.01.2024
PC3I researchers found that a combination of patient- and clinician-directed nudges can increase the completion rate of serious illness conversations (SICs) between patients with cancer and their clinicians.
PC3I News
PC3I Presents 35 Abstracts at the 2024 ASCO Annual Meeting
05.30.2024
PC3I Faculty, Fellows, and Staff present 35 abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL under the theme "The Art and Science of Cancer Care: From Comfort to Cure."
PC3I News
Justin Bekelman Appointed as Marietta and Howard Stoeckel Professor
05.15.2024
PC3I Director Justin Bekelman, MD has been appointed as the inaugural Marietta and Howard Stoeckel Professor at the Perelman School of Medicine at the University of Pennsylvania.